2,109
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Conducting hematopoietic stem cell transplantation in low and middle income countries

ORCID Icon, &

References

  • Ruiz-Argüelles GJ. Lessons learned starting a bone marrow transplantation programme in a resource-constrained setting. Lancet Haematol. 2020 Jul;7(7):e509–e510. doi:10.1016/S2352-3026(20)30184-8. PMID: 32589976.
  • Jaimovich G, Gale RP, Hanesman I, et al. The paradox of haematopoietic cell transplant in Latin America. Bone Marrow Transplant. 2021 Oct;56(10):2382–2388. doi:10.1038/s41409-021-01321-x. Epub 2021 May 13. PMID: 33986498.
  • Frutos C, Enciso ME, von Glasenapp A, et al. Bridging the gap using telemedicine: optimizing an existing autologous hematopoietic SCT unit into an allogeneic hematopoietic SCT unit in Paraguay with the help of the WBMT. Blood Adv. 2019 Dec 6;3(Suppl 1):45–47. doi:10.1182/bloodadvances.2019GS121781. PMID: 31809552; PMCID: PMC7034120.
  • López-Otero A, Ruiz-Delgado GJ, Ruiz-Argüelles GJ. A simplified method for stem cell autografting in multiple myeloma: a single institution experience. Bone Marrow Transplant. 2009 Dec;44(11):715–719. doi:10.1038/bmt.2009.71. Epub 2009 Apr 6. PMID: 19349952.
  • Karduss-Urueta A, Gale RP, Gutierrez-Aguirre CH, et al. Freezing the graft is not necessary for autotransplants for plasma cell myeloma and lymphomas. Bone Marrow Transplant. 2018 Apr;53(4):457–460. doi:10.1038/s41409-017-0047-7. Epub 2018 Jan 12. PMID: 29330390.
  • Fernández-Gutiérrez JA, Reyes-Cisneros OA, Litzow MR, et al. High dose melphalan is an adequate preparative regimen for autologous hematopoietic stem cell transplantation in relapsed/refractory lymphoma. Hematology. 2022;27:449–455.
  • Gale RP, Ruiz-Argüelles GJ. The big freeze may be over: a contracting universe for cryopreservation? Bone Marrow Transplant. 2018;53:947–948.
  • Murrieta-Álvarez I, Cantero-Fortiz Y, León-Peña AA, et al. The 1,000th transplant for multiple sclerosis and other autoimmune disorders at the HSCT-México Program: A myriad of experiences and knowledge. Front Neurol. 2021 Feb 22;12:647425, doi:10.3389/fneur.2021.647425. PMID: 33692748; PMCID: PMC7937693.
  • Ruiz-Argüelles GJ, Olivares-Gazca JC, Olivares-Gazca M, et al. Self-reported changes in the expanded disability status scale score in patients with multiple sclerosis after autologous stem cell transplants: real-world data from a single center. Clin Exp Immunol. 2019: 351–358. doi:10.1111/cei.13358. Epub 2019 Aug 19. PMID: 31394007; PMCID: PMC6857075.
  • Gómez-Almaguer D, Ruiz-Argüelles GJ, Ruiz-Argüelles A, et al. Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases. Bone Marrow Transplant. 2000 Jan;25(2):131–133. doi:10.1038/sj.bmt.1702100. PMID: 10673669.
  • Gómez-Almaguer D, Gómez-De León A, Colunga-Pedraza PR, et al. Outpatient allogeneic hematopoietic stem-cell transplantation: a review. Ther Adv Hematol. 2022 Feb 26;13:20406207221080739, doi:10.1177/20406207221080739. PMID: 35237396; PMCID: PMC8882949.
  • Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, Jaime-Pérez JC, et al. Low incidence and severity of graft-versus-host disease after outpatient allogeneic peripheral blood stem cell transplantation employing a reduced-intensity conditioning. Eur J Haematol. 2011 Dec;87(6):521–530. doi:10.1111/j.1600-0609.2011.01702.x. PMID: 21883482.
  • Ruiz-Delgado GJ, Mancias-Guerra C, Macias-Gallardo J, et al. Long-term results of placental blood allografting using reduced-intensity conditioning: multicenter experience in a developing country. Hematology. 2011 May;16(3):155–159. doi:10.1179/102453311X12953015767572. PMID: 21669055.
  • Ruiz-Argüelles GJ, Ruiz-Delgado GJ, González-Llano O, et al. Haploidentical bone marrow transplantation in 2015 and beyond. Curr Oncol Rep. 2015 Dec;17(12):57, doi:10.1007/s11912-015-0482-9. PMID: 26467275.
  • González-Llano O, González-López EE, Ramírez-Cázares AC, et al. Haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide in children and adolescents with hematological malignancies. Pediatr Blood Cancer. 2016 Nov;63(11):2033–2037. doi:10.1002/pbc.26131. Epub 2016 Jul 9. PMID: 27394055.
  • Murrieta-Álvarez I, Ruiz-Argüelles GJ. Bien plus encore: Haplos indeed can be completed on an outpatient basis. Transplant Cell Ther. 2021 Jun;27(6):519–520. doi:10.1016/j.jtct.2021.03.009. Epub 2021 Mar 8. PMID: 33819480.
  • León-González M, León-Peña AA, Vallejo-VIllalobos MF, et al. Mexican biosimilar filgrastim for autologous hematopoietic stem cell mobilization and transplantation. Rev Invest Clin. 2016 Jul-Aug;68(4):181–183. PMID: 27623036.
  • León A G-D, Bugarin-Estrada E, Colunga-Pedraza PR, et al. Efficacy of three filgrastim-intended copies for hematopoietic stem cell mobilization in healthy adult and pediatric donors in Mexico. J Clin Apher. 2019 Oct;34(5):537–544. doi:10.1002/jca.21707. Epub 2019 Apr 4. PMID: 30946494.
  • Gutiérrez-Aguirre CH, Alvarado-Navarro DM, Palomares-Leal A, et al. Reduced-dose plerixafor as a mobilization strategy in autologous hematopoietic cell transplantation: a proof of concept study. Transfusion. 2019 Dec;59(12):3721–3726. doi:10.1111/trf.15547. Epub 2019 Oct 16. PMID: 31618456.
  • Jaime-Pérez JC, Villarreal-Villarreal CD, Salazar-Riojas R, et al. Increased bacterial infections after transfusion of leukoreduced non-irradiated blood products in recipients of allogeneic stem cell transplants after reduced-intensity conditioning. Biol Blood Marrow Transplant. 2015;21:526–530.
  • Ruiz-Argüelles GJ. The gross national product does not support the intelligent national product. Medicina Univ. 2009;11:147–148.